Blue Owl Capital Holdings LP Context Therapeutics Inc. Transaction History
Blue Owl Capital Holdings LP
- $234 Million
- Q4 2024
A detailed history of Blue Owl Capital Holdings LP transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Blue Owl Capital Holdings LP holds 6,357,928 shares of CNTX stock, worth $5.21 Million. This represents 2.69% of its overall portfolio holdings.
Number of Shares
6,357,928
Previous 5,411,290
17.49%
Holding current value
$5.21 Million
Previous $10.6 Million
40.66%
% of portfolio
2.69%
Previous 3.5%
Shares
3 transactions
Others Institutions Holding CNTX
# of Institutions
50Shares Held
60.3MCall Options Held
0Put Options Held
0-
Bio Impact Capital LLC Cambridge, MA14.7MShares$12.1 Million2.18% of portfolio
-
Avidity Partners Management LP Dallas, TX7.48MShares$6.13 Million0.84% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$6.08 Million0.32% of portfolio
-
Nextech Invest Ag7.42MShares$6.08 Million1.37% of portfolio
-
Great Point Partners LLC Greenwich, CT4.68MShares$3.84 Million3.06% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $13.1M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...